- Home
- RRGB vs CMRX Comparison
RRGB vs CMRX Comparison
Compare RRGB & CMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RRGB
- CMRX
- Stock Information
- Founded
- RRGB 1969
- CMRX 2000
- Country
- RRGB United States
- CMRX United States
- Employees
- RRGB N/A
- CMRX N/A
- Industry
- RRGB Restaurants
- CMRX Biotechnology: Pharmaceutical Preparations
- Sector
- RRGB Consumer Discretionary
- CMRX Health Care
- Exchange
- RRGB Nasdaq
- CMRX Nasdaq
- Market Cap
- RRGB 91.6M
- CMRX 77.1M
- IPO Year
- RRGB 2002
- CMRX 2013
- Fundamental
- Price
- RRGB $5.56
- CMRX $3.55
- Analyst Decision
- RRGB Strong Buy
- CMRX Strong Buy
- Analyst Count
- RRGB 3
- CMRX 2
- Target Price
- RRGB $12.50
- CMRX $8.50
- AVG Volume (30 Days)
- RRGB 277.1K
- CMRX 1.6M
- Earning Date
- RRGB 02-26-2025
- CMRX 02-27-2025
- Dividend Yield
- RRGB N/A
- CMRX N/A
- EPS Growth
- RRGB N/A
- CMRX N/A
- EPS
- RRGB N/A
- CMRX N/A
- Revenue
- RRGB $1,272,359,000.00
- CMRX $159,000.00
- Revenue This Year
- RRGB N/A
- CMRX N/A
- Revenue Next Year
- RRGB $0.95
- CMRX $1,690.28
- P/E Ratio
- RRGB N/A
- CMRX N/A
- Revenue Growth
- RRGB N/A
- CMRX N/A
- 52 Week Low
- RRGB $2.97
- CMRX $0.75
- 52 Week High
- RRGB $11.25
- CMRX $3.80
- Technical
- Relative Strength Index (RSI)
- RRGB 52.18
- CMRX 66.31
- Support Level
- RRGB $5.31
- CMRX $3.25
- Resistance Level
- RRGB $5.99
- CMRX $3.72
- Average True Range (ATR)
- RRGB 0.38
- CMRX 0.30
- MACD
- RRGB 0.00
- CMRX -0.07
- Stochastic Oscillator
- RRGB 38.79
- CMRX 63.24
About RRGB Red Robin Gourmet Burgers Inc.
Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. Its brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue.
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.